On January 8, the Hong Kong capital market welcomed three companies listing on the same day. The exclusive industry advisor Frost & Sullivan extends its warmest congratulations.Zhipu Huazhang (2513.HK),Dayshi Smartchip (9903.HK),Jingfeng Medical (2675.HK)Successfully listed on the Hong Kong Stock Exchange!
All three companies have chosen Frost & Sullivan (Frost & Sullivan, abbreviated as Frost & Sullivan) as their trusted partner, providing them with exclusive industry advisory services! We cherish and are grateful for the choices and trust of our customers, and we will live up to our commitments, continuing to accompany more companies in achieving higher-quality development in the capital market with our professional services!
Frost & Sullivan (Frost & Sullivan) has always been a leader in helping companies go public in Hong Kong, boasting rich industry experience and communication skills with regulatory authorities, exchanges, investment and financing institutions, and various related organizations. According to LiveReport's big data, from January to December 2025, as well as over a 36-month statistical period, Frost & Sullivan provided listing industry advisory services to 83 (accounting for 72% of the market share) and 180 (accounting for 71% of the market share) successful Hong Kong IPO companies, ranking first in terms of number.
Recommended Reading

Beijing Zhipu Huazhang Technology Co., Ltd. (Stock Code: 2513.HK)
Beijing Zhipu Huazhang Technology Co., Ltd.A Chinese AI company dedicated to developing general-purpose large models, with its core business being model-as-a-service developmentMaaS) products, as well as a commercial platform for developing large model services to provide to customers.

Shanghai Daysight Semiconductor Co., Ltd. (Stock Code: 9903.HK)
Shanghai days Semiconductor Co., Ltd.It is the first in China to mass-produce training general-purpose GPU chips and achieve inference.Universal GPU chipMass-produced, and it is the first chip design company to achieve this milestone using the advanced 7-nanometer process.

Jingfeng Medical Technology Co., Ltd. (Stock Code: 2675.HK)
Jingfeng Medical Technology Co., Ltd.It is an innovative medical device company focusing on advanced surgical robots, dedicated to providing systematic solutions for minimally invasive and non-invasive surgeries through self-developed products such as porous endoscopes, single-port endoscopes, and natural orifice surgical robots. The company aims to promote the application and popularization of surgical robots in multidisciplinary clinical scenarios.
During the process of an enterprise going public in Hong Kong, Frost & Sullivan mainly undertakes the following tasks: helping issuers accurately and objectively understand their positioning in the target market, using objective market data to discover, support, and highlight the issuer's competitive advantages, assisting the issuer, investment banks, and other intermediaries in completing the relevant parts of the prospectus (such as the overview, competitive advantages and strategy, industry overview, business, and other important sections), helping the issuer complete communication with the Hong Kong Stock Exchange and investors, assisting investors in quickly understanding the market ecosystem and competitive landscape, and assisting the issuer in completing feedback on various industry-related issues from the Hong Kong Stock Exchange, etc.
Since the Frost & Sullivan team began providing investment and financing advisory services to corporate leaders and their management teams, it has helped nearly 3,000 companies successfully list on the Hong Kong stock market and domestically and internationally, making it a leading enterprise in the field of domestic investment and financing strategy consulting. Frost & Sullivan has long cooperated closely with globally renowned investment banks, accounting firms, law firms, investment institutions, and industry-leading companies, establishing an efficient domestic platform for matching investment and financing needs, and is capable of quickly forming comprehensive advisory service teams. Over the past decade, Frost & Sullivan has consistently ranked first in the market share of professional industry advisory services for Chinese companies listing on the Hong Kong stock market and overseas; in recent years, Frost & Sullivan reports have also been widely cited in the prospectuses, primary and secondary market research reports, and other capital market disclosure documents of leading A-share and STAR Market companies in the industry.


